IGFBP6 and central nervous system cancer: The genes Lysyl Oxidase Like 1 (LOXL1) and Insulin Like Growth Factor Binding Protein 6 (IGFBP6) were consistently selected and linked to glioma survival, emphasising their clinical significance.